透過您的圖書館登入
IP:3.139.107.241
本文另有預刊版本,請見:10.6200/TCMJ.202010/PP.0014

摘要


嚴重特殊傳染性肺炎(COVID-19)疫情,是在2019年至2020年間由嚴重急性呼吸系統症候群冠狀病毒2(SARS-CoV-2)所引發的全球大流行。新冠病毒的感染除了發燒、咳嗽、肺炎等主要呼吸道症狀之外,也會造成結膜炎。雖然現有文獻顯示COVID-19病人在眼部的表現是相對罕見的。然而結膜炎可能是感染COVID-19早期出現的唯一症狀,因此臨床眼科醫師必須了解COVID-19,並擬定相關應變計劃與防護措施,除提供醫療服務外,同理關懷病人與家屬心靈,並適當使用個人防護,以維護自身的安全。本文除了對COVID-19在眼科的表現進行文獻回顧外,並簡述臺北市立聯合醫院眼科部面對疫情所實施的應變計劃。應變計劃分為門診、手術、住院、急診與會診、會議與後疫情時期未來展望等部分,並隨即時疫情與文獻進行滾動式調整。期望臺北市立聯合醫院眼科團隊在疫情威脅下仍能秉持「以人為中心」的理念,持續提供高價值醫療服務,提升病患與員工同仁的安全,為台灣眼科醫療做出具體的貢獻。

並列摘要


Coronavirus disease 2019 (COVID-19) is a virus pandemic caused by severe acute respiratory syndrome coronavirus 2. Besides major respiratory symptoms such as fever, cough, and meningitis, infection of the virus also causes conjunctivitis. Although current studies revealed that the presentations in the eyes of COVID 19 patients are relatively rare, the presence of SARS-Cov-2 in ocular secretions and conjunctivitis could be the only first symptom of COVID-19. Thus, ophthalmologists should have an understanding of COVID-19 and develop related contingency plans and preventive measures. We aimed to provide medical services and, in the meantime, to show empathy and care on patients and their family members, and to use appropriate protection to ensure personal safety. We reviewed the COVID-19 presentations in ophthalmology and described the Guidelines of contingency plans implemented by the Department of Ophthalmology of Taipei City Hospital for the outbreak of COVID-19 in this article. The contingency plan includes sections of outpatient clinics, surgery, hospitalization, emergency and consultation, conference and future outlook during the post-epidemic period, and adjusts in a rolling manner with the immediate epidemic situation and emerging literature. We expect the ophthalmology team of the Taipei City Hospital to be remained committed to people-centered care. At the same time, under the threat of the pandemic, we continue to provide high-value medical services, improve patient and employee safety, and make specific contributions to ophthalmological medicine in Taiwan.

延伸閱讀